Dealflow | June 29, 2017

Cardiotrack to invest in Mexican operations and training, amid expansion

ImpactAlpha
The team at

ImpactAlpha

Cardiovascular disease is the leading cause of death worldwide; 75% of heart-disease related deaths are in low- and middle-income countries.

Most diagnostic tools are designed for large, urban hospitals.

“They are often too expensive and require a significant amount of training. That makes them unsuitable for primary care physicians,” particularly in non-urban areas,” Cardiotrack’s Avin Agrawal said in an interview.

The Singapore- and Bangalore-based healthcare diagnostics company developed a low-cost electrocardiogram that pairs with predictive software to detect heart conditions and disease.

The tool was launched in 2014 for under-resourced public health centers in India, and has also launched via partners in Mexico and France.

The Mexican state of Nuevo León has signed an agreement with Cardiotrack to establish a local base of operations in the capital, Monterrey, and open a training unit that will create 200 local jobs.